naproxen has been researched along with s 1743 in 28 studies
| Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (s 1743) | Trials (s 1743) | Recent Studies (post-2010) (s 1743) |
|---|---|---|---|---|---|
| 4,551 | 1,057 | 1,429 | 1,228 | 569 | 704 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 22 (78.57) | 24.3611 |
| 2020's | 6 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Fort, JG; Miner, P; Orlemans, E; Plachetka, J; Sostek, M | 1 |
| Fort, JG; Goldstein, JL; Hochberg, MC; Hwang, C; Sostek, M; Zhang, Y | 1 |
| Estborn, L; Fort, JG; Sostek, MB; Vikman, K | 1 |
| Dhillon, S | 1 |
| Fort, JG; Hochberg, MC; Hwang, C; Sostek, M; Svensson, O | 1 |
| Fort, J; Sostek, M; Wang-Smith, L; Zhang, Y | 1 |
| Cryer, BL; Fort, JG; Hochberg, MC; Hwang, C; Sostek, MB; Svensson, O | 1 |
| Angiolillo, DJ; Datto, C; Desai, B; Hwang, C; Sostek, M | 1 |
| Danabal, P; Gopinath, S; Kumar, RS; Shankar, MB | 1 |
| Angiolillo, DJ; Datto, C; Raines, S; Yeomans, ND | 1 |
| Choi, HG; Im, YJ; Jeon, JY; Jin, C; Kim, EY; Kim, H; Kim, MG; Kim, Y; Kwak, SS; Lee, SY; Wang, HM | 1 |
| De Beer, M; De Beer, T; Monteyne, T; Remon, JP; Vervaet, C; Voorspoels, J; Vynckier, AK | 1 |
| Amer, SM; Lotfy, HM; Mostafa, NS; Zaazaa, HE | 1 |
| Choi, Y; Han, H; Lim, KS; Shin, D; Yu, KS | 1 |
| Bello, AE; Fort, JG; Grahn, AY; Holt, RJ; Kent, JD | 1 |
| Kan, S; Liu, J; Lu, J; Zhang, W; Zhao, Y | 1 |
| Brozoski, DT; Calvo, AM; Dionísio, TJ; Faria, FA; Lauris, JR; Santos, CF; Simoneti, LF; Torres, EA; Weckwerth, GM; Zupelari-Gonçalves, P | 1 |
| El-Kimary, EI; Ragab, MAA | 1 |
| Bao, W; Borer, JS; Graham, DY; Husni, ME; Libby, P; Lincoff, AM; Lüscher, TF; Nissen, SE; Solomon, DH; Stevens, T; Vargo, J; Walker, C; Wang, Q; Wisniewski, LM; Wolski, KE; Yeomans, ND | 1 |
| Alpan, O; Ball, J; Dare, JA; Francis-Sedlak, M; Goldsmith, D; Gottlieb, B; Gupta, R; Holt, RJ; Jerath, R; Jung, L; LaMoreaux, BD; Lovell, DJ; Naddaf, H; Reinhardt, A; Von Scheven, E; Zeft, A | 1 |
| Amazonas, RB; Bocchi de Oliveira, MF; Ecclissato, C; Macêdo, EA; Pott Júnior, H; Scheinberg, M | 1 |
| Kang, CN; Kim, HJ; Kim, JH; Lee, S; Lee, WS; Moon, SH; Park, MS; Shin, SJ | 1 |
| Kwon, Y; Park, D | 1 |
| Calvo, AM; Dionísio, TJ; Faria, FC; Morettin, M; Oliveira, GM; Santos, CF | 1 |
| Li, X; Sun, L; Yang, Y; Zhang, T; Zhou, Q | 1 |
| An, H; Shin, D | 1 |
| Calvo, AM; Dionísio, TJ; Faria, FAC; Oliveira, GM; Polanco, NLDH; Santos, CF; Siqueira-Sandrin, VS | 1 |
1 review(s) available for naproxen and s 1743
| Article | Year |
|---|---|
Naproxen/esomeprazole fixed-dose combination: for the treatment of arthritic symptoms and to reduce the risk of gastric ulcers.
Topics: Animals; Arthritis; Drug Combinations; Drug Dosage Calculations; Esomeprazole; Humans; Naproxen; Stomach Ulcer | 2011 |
17 trial(s) available for naproxen and s 1743
| Article | Year |
|---|---|
Clinical trial: evaluation of gastric acid suppression with three doses of immediate-release esomeprazole in the fixed-dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500 mg and enteric-coated esomeprazole 20 mg: a rand
Topics: Adolescent; Adult; Anti-Ulcer Agents; Clinical Trials, Phase I as Topic; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Esomeprazole; Female; Gastric Acid; Humans; Magnesium; Male; Middle Aged; Naproxen; Young Adult | 2010 |
Clinical trial: the incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen alone.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Esomeprazole; Humans; Incidence; Magnesium; Middle Aged; Naproxen; Osteoarthritis; Stomach Ulcer; Tablets, Enteric-Coated; Treatment Outcome; Young Adult | 2010 |
Long-term safety of naproxen and esomeprazole magnesium fixed-dose combination: phase III study in patients at risk for NSAID-associated gastric ulcers.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Dosage Forms; Drug Combinations; Esomeprazole; Female; Humans; Magnesium Compounds; Male; Middle Aged; Naproxen; Osteoarthritis; Risk Factors; Stomach Ulcer; Time Factors | 2011 |
Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials.
Topics: Celecoxib; Double-Blind Method; Drug Combinations; Esomeprazole; Humans; Naproxen; Osteoarthritis, Knee; Placebos; Pyrazoles; Sulfonamides; Treatment Outcome | 2011 |
Pharmacokinetics and relative bioavailability of a fixed-dose combination of enteric-coated naproxen and non-enteric-coated esomeprazole magnesium.
Topics: Administration, Oral; Adolescent; Adult; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Biological Availability; Capsules; Cross-Over Studies; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Humans; Least-Squares Analysis; Male; Middle Aged; Models, Biological; Naproxen; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Tablets, Enteric-Coated; Young Adult | 2012 |
A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Celecoxib; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Combinations; Dyspepsia; Esomeprazole; Female; Gastrointestinal Tract; Heartburn; Humans; Male; Middle Aged; Naproxen; Osteoarthritis, Knee; Pyrazoles; Sulfonamides; Tablets, Enteric-Coated; Treatment Outcome | 2011 |
Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Combinations; Esomeprazole; Female; Humans; Male; Middle Aged; Naproxen; Pilot Projects; Placebos; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Tablets, Enteric-Coated; Thromboxane B2; Time Factors; United States | 2011 |
Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Aspirin; Delayed-Action Preparations; Double-Blind Method; Esomeprazole; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Naproxen; Osteoarthritis | 2014 |
Pharmacokinetic comparison study of a combination containing 500 mg of Naproxen and 20 mg of Esomeprazole: a randomized, single-dose, 2-way crossover, open-label study in healthy Korean men.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Asian People; Biological Availability; Chemistry, Pharmaceutical; Cross-Over Studies; Drug Combinations; Esomeprazole; Humans; Male; Naproxen; Proton Pump Inhibitors; Republic of Korea; Tandem Mass Spectrometry; Therapeutic Equivalency; Young Adult | 2015 |
Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Chemistry, Pharmaceutical; Cross-Over Studies; Drug Combinations; Esomeprazole; Half-Life; Healthy Volunteers; Humans; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Naproxen; Proton Pump Inhibitors; Republic of Korea; Young Adult | 2015 |
Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Humans; Male; Middle Aged; Naproxen; Osteoarthritis, Knee; Pain; Pain Measurement; Proton Pump Inhibitors | 2015 |
Efficacy of naproxen with or without esomeprazole for pain and inflammation in patients after bilateral third molar extractions: A double blinded crossover study.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Esomeprazole; Female; Humans; Inflammation; Male; Molar, Third; Naproxen; Pain Management; Pain, Postoperative; Proton Pump Inhibitors; Tooth Extraction; Treatment Outcome; Young Adult | 2017 |
Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Aspirin; Celecoxib; Double-Blind Method; Drug Therapy, Combination; Esomeprazole; Female; Gastrointestinal Diseases; Humans; Ibuprofen; Male; Middle Aged; Naproxen; Osteoarthritis; Treatment Outcome | 2018 |
A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Child; Drug Therapy, Combination; Esomeprazole; Female; Follow-Up Studies; Humans; Male; Naproxen; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome; United States | 2018 |
Efficacy and safety of a fixed-dose combination of nimesulide/pantoprazole compared to naproxen/esomeprazole for pain relief in patients with osteoarticular diseases and dyspeptic symptoms.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Double-Blind Method; Dyspepsia; Esomeprazole; Female; Humans; Male; Middle Aged; Naproxen; Osteoporosis; Pain; Pain Management; Pantoprazole; Sulfonamides; Tablets | 2018 |
A comparative study of the efficacy of NAXOZOL compared to celecoxib in patients with osteoarthritis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Celecoxib; Double-Blind Method; Esomeprazole; Female; Gastrointestinal Diseases; Humans; Male; Naproxen; Osteoarthritis; Pain; Prospective Studies; Surveys and Questionnaires | 2020 |
Simultaneous separation of naproxen and 6-O-desmethylnaproxen metabolite in saliva samples by liquid chromatography-tandem mass spectrometry: Pharmacokinetic study of naproxen alone and associated with esomeprazole.
Topics: Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Esomeprazole; Female; Gastrointestinal Absorption; Humans; Male; Methanol; Middle Aged; Naproxen; Pain, Procedural; Reproducibility of Results; Saliva; Tablets; Tandem Mass Spectrometry; Young Adult | 2020 |
10 other study(ies) available for naproxen and s 1743
| Article | Year |
|---|---|
Naproxen/esomeprazole (Vimovo).
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Drug Combinations; Esomeprazole; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Naproxen; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Development and validation of a sensitive and high-throughput LC-MS/MS method for the simultaneous determination of esomeprazole and naproxen in human plasma.
Topics: Chromatography, Liquid; Drug Stability; Esomeprazole; High-Throughput Screening Assays; Humans; Linear Models; Naproxen; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Temperature | 2013 |
Enteric protection of naproxen in a fixed-dose combination product produced by hot-melt co-extrusion.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Citrates; Drug Combinations; Drug Compounding; Drug Stability; Esomeprazole; Naproxen; Spectroscopy, Fourier Transform Infrared; Tablets, Enteric-Coated | 2015 |
A comparative study of the novel spectrophotometric methods versus conventional ones for the simultaneous determination of Esomeprazole magnesium trihydrate and Naproxen in their binary mixture.
Topics: Cyclooxygenase Inhibitors; Drug Combinations; Esomeprazole; Naproxen; Proton Pump Inhibitors; Spectrophotometry; Tablets | 2015 |
Novel naproxen/esomeprazole magnesium compound pellets based on acid-independent mechanism: in vitro and in vivo evaluation.
Topics: Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biological Availability; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Implants; Esomeprazole; Excipients; Humans; Hydrogen-Ion Concentration; Male; Malondialdehyde; Naproxen; Nitric Oxide; Rats; Rats, Sprague-Dawley; Technology, Pharmaceutical | 2016 |
High performance liquid chromatography with photo diode array for separation and analysis of naproxen and esomeprazole in presence of their chiral impurities: Enantiomeric purity determination in tablets.
Topics: 2-Propanol; Chromatography, High Pressure Liquid; Esomeprazole; Hexanes; Limit of Detection; Naproxen; Omeprazole; Reproducibility of Results; Stereoisomerism; Tablets; Trifluoroacetic Acid | 2017 |
Factors Affecting Quality of Life and Satisfaction in Patients with Arthritis after Change to a Fixed-Dose Naproxen/Esomeprazole Combination Drug.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Drug Combinations; Esomeprazole; Female; Humans; Male; Middle Aged; Naproxen; Personal Satisfaction; Prospective Studies; Quality of Life; Surveys and Questionnaires; Young Adult | 2020 |
Simultaneous determination of naproxen and esomeprazole in beagle dog plasma by supercritical fluid chromatography-tandem mass spectrometry coupled with evaporation-free liquid-liquid extraction.
Topics: Animals; Chromatography, Supercritical Fluid; Dogs; Esomeprazole; Limit of Detection; Liquid-Liquid Extraction; Naproxen; Reproducibility of Results; Tandem Mass Spectrometry | 2021 |
Multivariate Assessment for Bioequivalence Based on the Correlation of Random Effect.
Topics: Area Under Curve; Biological Availability; Biphenyl Compounds; Datasets as Topic; Drug Combinations; Esomeprazole; Humans; Linear Models; Male; Models, Statistical; Multivariate Analysis; Naproxen; Pyrimidines; Randomized Controlled Trials as Topic; Tetrazoles; Therapeutic Equivalency; Tramadol | 2021 |
Simultaneous separation of naproxen and 6-O-desmethylnaproxen metabolite in saliva samples by liquid chromatography-tandem mass spectrometry: Pharmacokinetic study of naproxen alone and associated with esomeprazol-Results.
Topics: Chromatography, Liquid; Esomeprazole; Humans; Naproxen; Saliva; Tandem Mass Spectrometry | 2022 |